Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
Chekhun S, Lopez-Paradís A, Urbizu A, Morán T, Mañes A, Cucurull M, Martínez-Barenys C, Teruel I, Moragas G, Carcereny E, Muñoz Mármol AM, Saigí M.
Chekhun S, et al. Among authors: moran t.
Explor Target Antitumor Ther. 2023;4(6):1182-1187. doi: 10.37349/etat.2023.00191. Epub 2023 Dec 13.
Explor Target Antitumor Ther. 2023.
PMID: 38213544
Free PMC article.